CSIMarket
 


Collegium Pharmaceutical Inc   (COLL)
Other Ticker:  
 
 

COLL's EPS from Cont. Operations Growth by Quarter and Year

Collegium Pharmaceutical Inc 's EPS from Cont. Operations results by quarter and year




COLL EPS from Cont. Operations (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 0.99 -0.21 -0.73 0.38
III Quarter September 0.61 0.01 0.23 0.33
II Quarter June 0.38 -0.15 2.06 0.23
I Quarter March -0.51 -0.39 0.45 -0.07
FY   1.47 -0.74 2.01 0.87



COLL EPS from Cont. Operations fourth quarter 2023 Y/Y Growth Comment
Collegium Pharmaceutical Inc in the fourth quarter 2023 achieved EPS from Cont. Operations of $ 0.99 compare to EPS loss from Cont. Operations recorded in same quarter a year ago.

According to the results reported in the fourth quarter 2023, Collegium Pharmaceutical Inc achieved the best EPS from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Collegium Pharmaceutical Inc ' s EPS from Cont. Operations no change of % ranks overall at the positon no. 26 in the fourth quarter 2023.




COLL EPS from Cont. Operations ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September 6000 % -95.65 % -30.3 % -
II Quarter June - - 795.65 % -
I Quarter March - - - -
FY   - - 131.03 % -

Financial Statements
Collegium Pharmaceutical Inc 's fourth quarter 2023 EPS from Cont. Operations $ 0.99 COLL's Income Statement
Collegium Pharmaceutical Inc 's fourth quarter 2022 EPS from Cont. Operations $ -0.21 Quarterly COLL's Income Statement
New: More COLL's historic EPS from Cont. Operations Growth >>


COLL EPS from Cont. Operations (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December 62.21 % - - 15.15 %
III Quarter September 60.53 % - -88.83 % 43.48 %
II Quarter June - - 357.78 % -
I Quarter March - - 18.42 % -
FY (Year on Year)   - - 131.03 % -




EPS from Cont. Operations fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #3
Overall #26

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
893.27 % 60.27 % -173.74 %
(Sep 30 2021)   (Mar 31 2023)
EPS from Cont. Operations fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #3
Overall #26
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
893.27 % 60.27 % -173.74 %
(Sep 30 2021)   (Mar 31 2023)

EPS from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Collegium Pharmaceutical Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
357.78 % 66.96 % -88.83 %
(Jun 30 2021)  


COLL's IV. Quarter Q/Q EPS from Cont. Operations Comment
Collegium Pharmaceutical Inc achieved in the IV. Quarter 2023 below company average EPS from Cont. Operations jump of 62.21% quarter on quarter, to $ 0.99 .

IV. Quarter 2023 performance were a mixed bag, although beneath the regular, yet it demonstrates a quite acceleration measured to the % in the IV. Quarter a year ago.

Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Collegium Pharmaceutical Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is 194.


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #3
Healthcare Sector #18
Overall #194
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #3
Healthcare Sector #18
Overall #194
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
357.78 % 66.96 % -88.83 %
(Jun 30 2021)  


COLL's IV. Quarter Q/Q EPS from Cont. Operations Comment
Collegium Pharmaceutical Inc achieved in the IV. Quarter 2023 below company average EPS from Cont. Operations jump of 62.21% quarter on quarter, to $ 0.99 .

Although the IV. Quarter 2023 COLL's performance was lower than the regular of 66.96 %, this was yet good story, as the IV. Quarter improvement, eclipses the % EPS from Cont. Operations surge in the same quarter a year ago

Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Collegium Pharmaceutical Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is 194.


Collegium Pharmaceutical Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative EPS from Cont. Operations 12 Months Ending $ 1.47 $ 0.27 $ -0.33 $ -0.86 $ -0.74
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) 444.26 % - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # 26 # 0 # 0 # 1337 # 1419




Cumulative EPS from Cont. Operations growth Comment
In the Dec 31 2023 period, Collegium Pharmaceutical Inc had cumulative twelve months EPS from Cont. Operations of $ 1 compare to EPS loss from Cont. Operations of $ -1 a year ago.
Not only that Major Pharmaceutical Preparations company has regained the prosperity, the company is already heading full steam with better then normal EPS from Cont. Operations rise, from the twelve months ending in the quarter Sep 30 2023 of 444.26 % from $0.27 .
Singns of revival, but very slow one, reporting beneth usual 444.26 % EPS from Cont. Operations rise, from $0.27 from the twelve months ending in the quarter Sep 30 2023.

Collegium Pharmaceutical Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
893.27 %
60.27 %
-173.74 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 3
S&P 500 # 26
Cumulative EPS from Cont. Operations growth Comment
In the Dec 31 2023 period, Collegium Pharmaceutical Inc had cumulative twelve months EPS from Cont. Operations of $ 1 compare to EPS loss from Cont. Operations of $ -1 a year ago.
Besides Major Pharmaceutical Preparations company has returned to bottom-line, the company is already improving fast with above average EPS from Cont. Operations gain, from the period from Sep 30 2023 to Dec 31 2022 of 444.26 % from $0.27 .
It is revival, but very slow one, recording less then standard 444.26 % EPS from Cont. Operations rise, from $0.27 from the twelve months ending in the quarter before Isabelle Taylor mentioned.

Collegium Pharmaceutical Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
893.27 %
60.27 %
-173.74 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 3
S&P 500 # 26




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
COLL's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for COLL's Competitors
EPS from Cont. Operations Growth for Collegium Pharmaceutical Inc 's Suppliers
EPS from Cont. Operations Growth for COLL's Customers

You may also want to know
COLL's Annual Growth Rates COLL's Profitability Ratios COLL's Asset Turnover Ratio COLL's Dividend Growth
COLL's Roe COLL's Valuation Ratios COLL's Financial Strength Ratios COLL's Dividend Payout Ratio
COLL's Roa COLL's Inventory Turnover Ratio COLL's Growth Rates COLL's Dividend Comparisons



Companies with similar EPS from Cont. Operations jump for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Dec 31 2023
Charles River Laboratories International inc -0.95%$ -0.946 
Regeneron Pharmaceuticals Inc -2.77%$ -2.768 
Docgo Inc -3.90%$ -3.902 
Haemonetics Corporation-4.62%$ -4.615 
Edwards Lifesciences Corporation-5.96%$ -5.957 
Resmed Inc -7.19%$ -7.190 
Bristol myers Squibb Company-8.40%$ -8.397 
Gilead Sciences Inc -12.83%$ -12.832 
Utah Medical Products Inc-14.12%$ -14.124 
Masimo Corp-17.78%$ -17.782 
Merit Medical Systems Inc-18.28%$ -18.277 
Qiagen N v -19.35%$ -19.355 
Fresenius Medical Care Ag-26.09%$ -26.087 
Mettler toledo International Inc -28.51%$ -28.506 
Avantor Inc -30.61%$ -30.610 
Amedisys Inc -39.32%$ -39.315 
Avanos Medical Inc -39.47%$ -39.469 
Becton Dickinson And Company-43.27%$ -43.275 
Embecta Corp -43.55%$ -43.548 
Pro dex Inc -44.00%$ -44.000 
Harmony Biosciences Holdings inc -44.04%$ -44.044 
Bio techne Corp-46.88%$ -46.875 
Star Equity Holdings Inc -47.42%$ -47.416 
Amgen Inc -52.75%$ -52.746 
Biogen Inc -54.98%$ -54.977 
Taro Pharmaceutical Industries Ltd-56.13%$ -56.129 
Bio rad Laboratories Inc -56.74%$ -56.736 
Integra Lifesciences Holdings Corp-60.46%$ -60.461 
Henry Schein Inc-60.47%$ -60.467 
Teleflex Incorporated-60.61%$ -60.605 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com